Thursday, March 29, 2012

Chelsea Fails to Win Backing for Dizziness Drug - Mar. 29, 2012

Having trouble viewing this email? View in Browser.
ClinicaSpace Focus
   Thursday, March 29, 2012 Advertising Information
subscriptions careernetwork news hotbeds careerfairs
Facebook  |  Linked In  |  Twitter  |  RSS  |  Subscribe

TOP SPONSOR

Reduce Risk and Maximize Potential in Ophthalmology Development

Ophthalmic study design and execution can be quite different than other therapeutic areas. Pharm-Olam's team has a proven track record of excellence in achieving trial objectives and can provide strategic, operational and consulting to sponsors for phase I to phase IV development.

The majority of our clinical staff in emerging markets are MDs or PhDs, including Ophthalmologists in strategic areas for clinical trials. The incidence of disorders and standards of treatment can vary widely, so let Pharm-Olam conduct a complimentary feasibility study specific to your protocol and study budgets to use in your resource planning.

Contact us at www.pharm-olam.com, info@pharm-olam.com, USA 1-713-559-7900, UK 44-0-1344-891121.
HeadHtml
•  Chelsea Therapeutics, Inc. (CHTP) Fails to Win Backing for Dizziness Drug More...
•  FDA Extends Review of Forest Laboratories, Inc. (FRX) Lung Drug; Action Now Seen in July More...
More BLA/NDA/ANDA News
More IND News
More MAA News
HeadHtml
•  Eli Lilly and Company (LLY)'s Ixekizumab Met Primary Endpoint in Phase II Study in Patients With Plaque Psoriasis More...
•  Nile Therapeutics, Inc. Announces Positive Clinical Trial Results Evaluating the Subcutaneous Infusion of Cenderitide More...
•  Genzyme Corporation (GENZ) Release: KYNAMRO™ (mipomersen sodium) Data Presented at XVI International Symposium on Atherosclerosis More...
•  Veloxis Pharmaceuticals A/S (VELO) Completes Enrolment in LCP-Tacro™ 3002 Pivotal Phase III Trial in Kidney Transplant More...
•  Amgen (AMGN) Announces Phase 2 Study Results for Brodalumab in Moderate to Severe Plaque Psoriasis Published in the The New England Journal of Medicine More...
More Phase III News
More Phase II News
More Phase I News
More Pre-Clinical News
More Post-Approval News
Featured Free Resource

Building Novel Applications with Pipeline Pilot to Drive Next Generation Sequencing

This case study shows how scientists are streamlining the process of analyses of DNA sequence information. Enabled by new DNA sequencing technologies, many more scientists and informaticians are interrogating larger and more complex data set.

Request Now!
HeadHtml
•  Can Antibiotics Make You Fat? New York University Reveals More...
•  Vitamin D-Fortified Yogurt Drink May Lower Risk of Heart Disease in Type 2 Diabetics, Shahid Beheshti University of Medical Sciences Study More...
•  Antipsychotic Drugs Might Raise Heart Attack Risk, Universite Bordeaux Segalen Study More...
•  Early Dose of Glucose Thwarts Cardiac Arrest, Tufts Medical Center Study More...
•  Complicated Link Between Diet Drinks, Health; University of North Carolina Study More...
More General Clinical Research News
Events

CHI's 8th Annual
PEGS: The Protein Engineering Summit
April 30- May 4 | Boston, MA
www.PEGSummit.com

Cambridge Healthtech Institute is proud to present the Eighth Annual PEGS protein engineering summit. This comprehensive event encompasses 12 tracks, 15 short courses, and a pre-conference partnering forum for showcasing early stage companies. Topics span from early stage discovery of new methods for protein expression and antibody engineering, to improved analytical techniques, and clinical results in the most promising areas of biotechnology. There is tremendous momentum and investment in biologics, and the PEGS event offers an unparalleled view of the field. Make plans to join us this April in Boston.

To register and for more information, visit www.PEGSummit.com.
Latest Market Insight

Biomarkers in Late Stage Clinical Trials

• Quantify and analyze revenues of late stage biomarker technology and services in North America, Europe, Asia and the Rest of the World.
• Identify the key market drivers and resistors of the biomarker market and evaluate the growth potential of emerging technologies.
• Assess biomarker activity at leading companies, including Abbott, AZ, BMS, Eli Lilly, GSK, Merck & Co, Novartis, Pfizer, Roche and Sanofi-Aventis.

Click Here for More Information.
Tower: Facebook
Top Jobs
Pharm Country (Bridgewater, New Jersey)

Omega Management Group
Clinical Quality Control Manager
Will manage the QC department in regards to clinical and regulatory documentation QC. In addition s/he will be responsible for the managing of the clinical departments SOPs in accordance with GCP guidelines. This includes training of responsible individuals within and across departments. In addition s/he will maintain and support QC audits of clinical Trial Master Files.

BioCapital (Rockville, Maryland)

Otsuka America Pharmaceutical, Inc.
Manager, Clinical Programming
Manages compound programming activities including the planning, coordination, and execution of the statistical programming functions in support of the clinical research project.

Biotech Beach (Irvine, California)

Allergan Inc.
Director, Clinical Development
Leads, directs and coordinates team activities (development and/or clinical) to ensure completion of the clinical development of projects of major importance to the corporation's long term future that are difficult and complex in nature and require the expert application of advanced knowledge in a broad area of science/technology.

Biotech Bay (Novato, California)

Ultragenyx Pharmaceutical Inc.
Senior Manager, Clinical Operations
Manages the operational aspects of clinical trials. Manages the study project plan, including timeline, budget, and resources. Participates in protocol, CRF and strategy development, Clinical Study Report preparation, NDA submission, as appropriate

BioMidwest (Hinckley, Ohio)

Clinical Research Management, Inc.
Clinical Research Associate
Manage the development, coordination, and implementation of clinical operations site management and clinical monitoring responsibilities for assigned projects with guidance, including trial-specific processes and systems.

• Get Noticed! Add your resume to the BioSpace Career Center!
• See more than 5,000 job postings in the BioSpace Career Center!


Biotech Beach

Biotech Beach Career Fair

Job seekers can spend a day with HR representatives and Hiring Managers from top biotech, pharma, medical device and diagnostics companies in the Southern California area.

Candidates with a 4-year degree in the life sciences and a minimum of 2-years of industry related experience are invited to attend. (Equivalent work experience may be considered in lieu of a four-year college degree. PhD and Postdoc candidates welcome.)

Exhibiting companies are recruiting for positions in areas such as: QA/QC, clinical research, engineering, manufacturing, biostatistics, clinical data management, chemistry, regulatory affairs, and research.

Job seekers may register here.

Biotech Beach Career Fair, La Jolla, CA April 17, 2012
BioCapital Career Fair, Bethesda, MD April 25, 2012
Pharm Country Career Fair, King Of Prussia, PA May 1, 2012
BioNC Career Fair, Durham, NC May 2, 2012
Biotech Bay Career Fair, Burlingame, CA May 29, 2012

More information about BioSpace's Career Fairs

BioSpace White Paper
Biotech Career Fairs For Job Seekers 101: Control Your Experience
By June Salvati, BioSpace Director of Events and Corporate Services
HeadHtml
•  Omeros Corporation (OMER) Reports Allowance of Additional Patent for Ophthalmology Product OMS302 More...
More Patent News
HeadHtml
•  Boehringer Ingelheim Corporation Cuts Pradaxa Price by 13 Percent in the UK More...
•  Roche (RHHBY) Cuts the Price of Cancer Drugs in India - Under Pressure? More...
•  Novartis Pharmaceuticals Canada Inc. (NVS) Release: Canadian Agency for Drugs and Technologies in Health (CADTH) Recommends Provincial and Publicly Funded Drug Plans Reimburse (Pr)Lucentis* to Treat Vision Loss Resulting From Diabetic Macular Edema (DME) More...
More Drug Product News
Feature

Hot Company

SNBL Clinical Pharmacology Center
800 West Baltimore Street, 5th Floor
Baltimore, Maryland 21201 U.S.A.
Phone: 800-690-9110 Fax: 410-706-8963

SNBL-CPC partners with pharmaceutical companies, biotech firms and CROs to accelerate drug development utilizing our best-in-class facility, technology, operational excellence and strong affiliations with local academic medical institutions (University of Maryland and Johns Hopkins University). A US subidiary of one the largest Clinical Reserach Organizations in Japan, SNBL-CPC is a Phase I/IIa clinical pharmacology center with both inpatient (96 beds) and outpatient facilities.

More Company Profiles
Contact Us

Post Your: News | Jobs | Company Profile | Event | Advertising / Sponsorship

ClinicaSpace
6465 South Greenwood Plaza, Suite 400
Centennial, Colorado 80111 U.S.A.
Phone: 877-277-7585
Fax: 800-595-2929
ClinicaSpace
90 New Montgomery Street, Suite 414
San Francisco, California 94105 U.S.A.
Phone: 877-277-7585
Fax: 415-576-9217

Send questions and comments to the ClinicaSpace News Beat Team.

Editor & Publisher: Rosemary Do
Editorial & Production Staff: Lana Ho, Maysa Darwish, Tammy Liu, Michelle Wong

ClinicaSpace.com - Clinical Trials. Clinical Research. Community.
Legal Notice
• ClinicaSpace is a registered trademark of BioSpace, Inc.
• Please distribute this e-cast freely.
• Credit any excerpts as follows:
Copyright 2012 ClinicaSpace http://www.clinicaspace.com
• While BioSpace and its agents used their best efforts in collecting and preparing the information published herein, we do not assume, and hereby disclaim, any liability for any loss or damage caused by errors or omissions, whether such errors or omissions resulted from negligence, accident or other causes.
Subscribe/Unsubscribe
If someone forwarded this news to you and you'd like to receive your own copy FREE of charge, simply Subscribe here.

Safely unsubscribe from ClinicaSpace.com e-mail at any time by managing your account here.
 


No comments: